Occupe actuellement des postes chez Neurocrine Biosciences Inc, Fate Therapeutics Inc, Regulus Therapeutics Inc and Dare Bioscience Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Neurocrine Biosciences Inc | 1 mai 2011 - |
Independent Chairman of the Board | Fate Therapeutics Inc | 1 novembre 2011 - |
Independent Director | Regulus Therapeutics Inc | 1 avril 2013 - |
Lead Independent Director | Dare Bioscience Inc | None - |
Independent Chairman of the Board | Illumina Inc | 27 janvier 2005 - 28 janvier 2016 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-05-03 | 2023-05-01 |
Neurocrine Biosciences Inc
(NBIX)
|
VP Vente planifiée |
4 300
-9.1%
101,43436 135 USD |
4 300 -9.1% | 101,43 | 436 135 USD | |
2023-04-21 | 2023-04-21 |
Neurocrine Biosciences Inc
(NBIX)
|
VP Vente planifiée |
6 034
-13.3%
105,04633 787 USD |
6 034 -13.3% | 105,04 | 633 787 USD | |
2023-04-21 | 2023-04-19 |
Neurocrine Biosciences Inc
(NBIX)
|
VP Vente planifiée |
903
-2.5%
105,0094 819 USD |
903 -2.5% | 105,00 | 94 819 USD | |
2022-04-05 | 2022-04-01 |
Neurocrine Biosciences Inc
(NBIX)
|
VP Vente planifiée |
10 728
-24.0%
94,931 018 366 USD |
10 728 -24.0% | 94,93 | 1 018 366 USD | |
2019-05-08 | 2019-05-07 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
92 889
+151.4%
1,08100 320 USD |
92 889 +151.4% | 1,08 | 100 320 USD | |
2017-07-25 | 2017-07-25 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
274 725
+78.5%
0,91250 000 USD |
274 725 +78.5% | 0,91 | 250 000 USD | |
2017-03-07 | 2017-03-07 |
Regulus Therapeutics Inc
(RGLS)
|
A Achat |
250 000
+250.0%
1,15287 500 USD |
250 000 +250.0% | 1,15 | 287 500 USD | |
2004-05-26 | 2004-05-24 |
Biogen Inc
(BIIB)
|
V Vente |
29 081
-26.9%
62,511 817 714 USD |
29 081 -26.9% | 62,51 | 1 817 714 USD | |
2004-05-20 | 2004-05-19 |
Biogen Inc
(BIIB)
|
V Vente |
25 000
-18.8%
60,031 500 750 USD |
25 000 -18.8% | 60,03 | 1 500 750 USD | |
2004-05-06 | 2004-05-04 |
Biogen Inc
(BIIB)
|
V Vente |
25 000
-13.5%
58,831 470 750 USD |
25 000 -13.5% | 58,83 | 1 470 750 USD | |
2004-05-06 | 2004-05-04 |
Biogen Inc
(BIIB)
|
V Vente |
80 000
-47.2%
58,684 694 400 USD |
80 000 -47.2% | 58,68 | 4 694 400 USD | |
2004-05-06 | 2004-05-04 |
Biogen Inc
(BIIB)
|
V Vente |
25 000
-12.8%
58,831 470 750 USD |
25 000 -12.8% | 58,83 | 1 470 750 USD |